Department of Orthpaedics, St. Vincent's Hospital, Melbourne, Australia.
Eur J Surg Oncol. 2010 Jan;36(1):84-8. doi: 10.1016/j.ejso.2009.07.183. Epub 2009 Aug 13.
While several modalities have been proposed for the treatment of desmoid tumour/aggressive fibromatosis, high local recurrence rates have been reported. We present a retrospective study of including patients treated with radiation therapy, some of them in combination with surgical resection.
Thirty-four consecutive patients were included (mean age 40+/-16 years, 9 male). Complete follow-up was available in 31 patients (51+/-36 months). Seventeen patients (50%) were treated with radiation therapy alone, 17 patients with radiation therapy and surgery. Radiation therapy (external beam) was applied in most cases to a total dose of 50.4 Gy in 28 fractions. The lesion was located in the upper extremity in 11 patients, in the lower extremity in 14 cases and on the trunk in 9 cases.
Overall recurrence/progression free survival was 88.5% at 5 years and 77.5% at 10 years. Recurrence free survival of the subset of patients undergoing combined treatment with radiation therapy and surgical resection was 83.6% at 5 years and 10 years. In patients who did not receive surgery but only radiation therapy, MRI showed a complete response in 20%, a partial response in 20%, and stable disease in 53% of cases. In this subset, two-third of patient had a metabolic response to radiotherapy (i.e. decrease uptake on the thallium-210 scan after radiotherapy compared to pre-therapy levels).
Low recurrence rates can be achieved with the use of radiation therapy alone in selected cases. Patients with a metabolic response (decrease) to radiotherapy may be treated with a non-surgical approach. Surgery might be considered in patients with a poor metabolic response to radiotherapy.
尽管已经提出了几种治疗硬纤维瘤/侵袭性纤维瘤的方法,但仍有报道称其局部复发率较高。我们报告了一项包括接受放射治疗的患者的回顾性研究,其中一些患者联合进行了手术切除。
共纳入 34 例连续患者(平均年龄 40+/-16 岁,9 名男性)。31 例患者可获得完整随访(51+/-36 个月)。17 例患者(50%)单独接受放射治疗,17 例患者接受放射治疗联合手术。在大多数情况下,采用外部束放射治疗,总剂量为 50.4Gy,共 28 个分次。病变位于上肢 11 例,下肢 14 例,躯干 9 例。
5 年和 10 年时总体无复发生存率分别为 88.5%和 77.5%。联合放射治疗和手术切除的患者亚组 5 年和 10 年时无复发生存率分别为 83.6%。未接受手术仅接受放射治疗的患者中,MRI 显示完全缓解 20%,部分缓解 20%,稳定疾病 53%。在该亚组中,三分之二的患者对放射治疗有代谢反应(即与治疗前相比,铊-210 扫描摄取减少)。
在某些选定的情况下,单独使用放射治疗可以实现低复发率。对放射治疗有代谢反应(减少)的患者可以采用非手术治疗方法。对放射治疗代谢反应差的患者可考虑手术。